Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study 201012: A Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With COPD

NCT02570165 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT02570165
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02570165 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study 201012: A Dose-Finding Study of Batefenterol (GSK961081) Via Dry Powder Inhaler in Patients With COPD
Lead sponsor
GlaxoSmithKline
Phase
Phase 2
Overall status
Completed
Start date
November 6, 2015
Completion date
July 6, 2016
Enrollment
325 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary disease, chronic obstructive